- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04343690
COPING With COVID-19( CWC-19)
September 22, 2020 updated by: Duke University
Effectiveness of Crisis Management Coaching on Faculty and Trainee Wellness During COVID-19 Crisis
The purpose of this study is 1) to understand effects of COVID-19 crisis on wellness of pulmonary and critical care faculty and trainees who are at frontline fighting this pandemic 2) Assess the effectiveness of series of weekly web based crisis management coaching from world renowned experts in coaching and 3) identify future areas of opportunities in physician wellness
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Any faculty, staff, or trainee from Duke pulmonary and critical care that consents to being in the study
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Health Care Workers
Faculty, staff, and trainees dealing with COVID-19 pandemic
|
Crisis management coaching will be offered to faculty, staff, and trainees dealing with COVID-19 pandemic
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in stress level as measured by survey
Time Frame: Baseline, mid-session (up to 4 weeks), post-intervention (up to 8 weeks)
|
Baseline, mid-session (up to 4 weeks), post-intervention (up to 8 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change wellness as measured by survey
Time Frame: Baseline, mid-session (up to 4 weeks), post-intervention (up to 8 weeks)
|
Survey is 14-items asking about wellness on a scale from "Strongly Agree" to "Not at all"
|
Baseline, mid-session (up to 4 weeks), post-intervention (up to 8 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 27, 2020
Primary Completion (ACTUAL)
May 1, 2020
Study Completion (ACTUAL)
May 1, 2020
Study Registration Dates
First Submitted
April 9, 2020
First Submitted That Met QC Criteria
April 10, 2020
First Posted (ACTUAL)
April 13, 2020
Study Record Updates
Last Update Posted (ACTUAL)
September 23, 2020
Last Update Submitted That Met QC Criteria
September 22, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00105319
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingCOVID-19 Testing BehaviorsUnited States
Clinical Trials on Crisis management coaching
-
Issam TanoubiCompletedPerformance of Non-anesthesiologists Residents for the Management of Sedation's Complications
-
Ottawa Hospital Research InstituteUniversity of TorontoCompleted
-
University of BeykentEnrolling by invitationCrisis InterventionTurkey
-
National University Hospital, SingaporeCompletedMedical Education, Simulation, Crisis Resource ManagementSingapore
-
Harvard School of Public Health (HSPH)Georgetown University; World Bank; Estonia Health Insurance FundCompletedMulti-morbidity | Non-communicable DiseasesEstonia
-
Queen's UniversityUniversity of GondarCompletedDiabetes Mellitus, Type 2 | Type 2 DiabetesCanada
-
Centre Hospitalier St AnneNot yet recruitingPsychiatric Hospitalization
-
Kaohsiung Kai-Suan Psychiatric HospitalNot yet recruitingThe Psychological Impact of COVID-19
-
Centre for Addiction and Mental HealthCompletedMajor Depressive Disorder | Cognition | Cannabis Use DisorderCanada
-
The University of Hong KongRecruitingCaregiver WellbeingHong Kong